Interpretation of the velocity measurement ballistocardiogram

Buckingham, William B.; Sutton, George C.; Rondinelli, Ray; Sutton, Don C.

doi:10.1016/0002-8703(53)90325-1

Cited by 3 publications

(1 citation statement)

References 12 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Ballistocardiography (BCG), originally discovered in the late 19 th century [1], has been the focus of intense research in 1940’s through the early 80’s, a period after which the method faded away (see Figure 1). This disappearance can be traced to a few general factors: 1) a lack of standard measurement techniques, with various methods leading to subtly different signals [2]; 2) a lack of understanding of the exact physiologic origin of the BCG waveform, as well as clear guidelines for interpretation of the results, leading to circumspection from the medical community; 3) a primary focus on clinical diagnostic (e.g., myocardial infarction, angina pectoris, coronary heart disease [3, 4]), which typically requires a high level of specificity and reliability that the BCG had not reached [5]; 4) the dawn of ultrasound and echocardiography techniques, which rapidly overtook BCG and related techniques for non-invasive cardiac and hemodynamic diagnostic.…”

Section: Introductionmentioning

confidence: 99%

Ballistocardiography — A method worth revisiting

Giovangrandi

Inan

Wiard

et al. 2011

2011 Annual International Conference of the IEEE Engineering in Medicine and Biology Society

142

View full text Add to dashboard Cite

The field of ballistocardiography seems to be enjoying a recent resurgence, most notably through the development of novel technologies and signal processing methods for measurement and analysis. After the method almost vanished in the late 80’s and 90’s, it is reasonable to wonder what is different this time, and if the technique has now more chances of becoming what its pioneer always wanted – a widespread clinical tool. This paper is an effort to compare and contrast this novel wave of research (notably in the context of the authors’ own work). It also suggests that the new approaches have several key differences with past embodiments that place them in a good position to address some specific issues such as cardiac resynchronization therapy device optimization or congestive heart failure monitoring. This optimism is largely fed by the recent technological advances enabling the measurement of the BCG unobtrusively, frequently, at home or in a hospital, and by a re-focus on monitoring and trending applications.

show abstract